Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|February 2, 2020
RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of KetamineLawrence Park, Maura Furey, Allison Nugent, et al.
Psychiatry Research|August 21, 2013
A developmental study on the neural circuitry mediating response flexibility in bipolar disorderJudah Weathers, Melissa A Brotman, Christen M Deveney, et al.
Journal of Affective Disorders|August 15, 2018
Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry settingMark Sinyor, Marissa Williams, Sue Belo, et al.
Brain Research|July 2, 2011
Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilienceJoshua G Hunsberger, Rodrigo Machado-Vieira, Daniel R Austin, et al.
The Journal of Clinical Psychiatry|October 28, 2020
Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant SymptomsPatricia T Spangler, James C West, Catherine L Dempsey, et al.
Archives of General Psychiatry|April 3, 2002
Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophreniaRobert W McCarley, Dean F Salisbury, Yoshio Hirayasu, et al.
Neurosurgical Review|March 18, 2024
Intraoperative ultrasound for surgical resection of high-grade glioma and glioblastoma: a meta-analysis of 732 patientsPavel S Pichardo-Rojas, Carlos Zarate, Julieta Arguelles-Hernández, et al.
Science Translational Medicine|September 30, 2011
Translating glutamate: from pathophysiology to treatmentDaniel C Javitt, Darryle Schoepp, Peter W Kalivas, et al.
Psychiatry Research|April 2, 2013
Abnormal fusiform activation during emotional-face encoding assessed with functional magnetic resonance imagingNancy E Adleman, Reilly R Kayser, Aviva K Olsavsky, et al.
Bipolar Disorders|May 22, 2019
What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithiumWillem A Nolen, Rasmus W Licht, Allan H Young, et al.
Pageof 4